Turkey's Economic Tightrope: Balancing Populism and Neoliberalism in Healthcare
"An in-depth look at how Turkey's AKP navigates the complexities of pharmaceutical policy, economic pressures, and political priorities."
Since November 2002, Turkey has been governed by the Justice and Development Party (AKP), a period often characterized by significant 'neoliberal restructuring.' Indeed, the early 2000s brought widespread privatization, reduced income tax rates, and flexible labor markets.
However, Turkey’s economic policies under the AKP have never fit neatly into a box. Its commitment to free market principles is regularly tempered by its conservative ideology and a strong desire to maintain support among both everyday citizens and powerful elites. This balancing act is visible in the expansion of social programs and the state’s continued role in housing.
A common thread in discussions of Turkish politics is the idea that the AKP is both neoliberal and populist. Drawing from studies of 'neoliberal populism' in Latin America, scholars have examined how the AKP combines these seemingly contradictory elements. This analysis is complex, given that 'populism' can refer to both redistribution policies and a political style centered on mass appeal and anti-establishment rhetoric.
Healthcare Systems Under Strain Globally
Healthcare systems worldwide face mounting pressure from rising costs, uneven access, and persistent inequities. In many middle-income countries, governments struggle to expand coverage while managing fiscal constraints. The tension between universal access aspirations and budgetary realities remains a defining challenge for health policy, with outcomes varying significantly across political and economic contexts.
Policy Frameworks and the Limits of Rational Decision-Making
Health policy development does not always follow a rational process of evaluation using established frameworks, theories, or models (FTMs), and greater utilization of such tools may overcome barriers to policy inaction. Despite higher per-capita healthcare spending than any other country, the United States lags far behind in health outcomes, with significant inequities by race, ethnicity, socioeconomic position, and rurality—demonstrating that spending alone does not guarantee results. Combining multi-criteria decision methods such as the Best-Worst Method with goal programming has been shown to improve the efficiency of resource allocation decisions in healthcare centers under limited budgets. Standardized service intensity assessment processes can provide a common language for care planning, yet translating frameworks into equitable real-world outcomes remains difficult.
A Century of Healthcare Policy Evolution
Health policy and reform efforts in the United States began in earnest in 1912, when Teddy Roosevelt and the Progressive Party endorsed social insurance as part of their platform, including health insurance. That same year, the National Convention of Insurance Commissioners developed its first model state law to regulate health insurance. Over the following century, milestones ranged from the Marine Hospital Service established in 1798 through modern legislation such as the Affordable Care Act and subsequent Medicaid restructuring debates. The history reflects a persistent tension between public provision and market-based approaches, with each era's political dynamics shaping the trajectory of coverage and access.
The 2009 Healthcare Reform: A Clash of Ideologies
In September 2009, Turkey initiated a major reform in its pharmaceutical expenditure and pricing policies. By introducing a global budget, the country saved approximately 20 billion TL in public pharmaceutical spending between 2010 and 2012. This substantial reduction was mainly achieved through stricter price controls on pharmaceutical producers and distributors—a populist solution.
- Electoral Considerations: The AKP's leadership recognized the importance of public health services to their voter base. Substantially reducing access could have triggered significant political backlash.
- Limited Business Influence: There was a notable absence of strong business interests advocating for high medicine prices. This reduced potential opposition to price control measures.
- Lack of Industrial Policy: The government lacked a developmentalist commitment to using pharmaceutical policy as a tool for broader industrial strategy. This removed another potential argument against price controls.
AKP Governance and Neoliberal Health Financing in Turkey
Recent scholarship examines how Turkey's AKP government has reshaped healthcare provision, particularly through the lens of social policy toward Kurdish populations. İlker Cörüt's study of healthcare provision in Hakkâri (2003–2014) illuminates state–citizen relations and reveals how healthcare access is mediated by political and ethnic dynamics. Research on the finance of health services during the AKP era characterizes the model as a neoliberal public health insurance framework, under which the state has shifted most of its financial responsibilities in health services onto the people over two decades of AKP governance. These studies collectively highlight how political ideology shapes both the structure and equity of healthcare delivery.
When Health Reform Falls Short
Research on factors associated with failure of health system reform identifies systemic obstacles including political instability, inadequate financing, and lack of stakeholder engagement as recurring causes of reform collapse. The United States healthcare system has been described as being in crisis, with employer healthcare costs rising 160% over the past 20 years to an average of about $14,000 per employee, placing downward pressure on wages and reducing household income by 8.9% in inflation-adjusted terms. Health policy challenges for 2025 and beyond include the expiration of enhanced ACA subsidies, physician payment rules, and prescription drug pricing disputes in Medicare. These failures illustrate that even well-resourced systems can falter when structural reforms are not sustained or when political will evaporates.
Cross-National Health Policy Comparisons
Comparative analysis of health systems reveals that no single model of healthcare delivery or financing has proven universally effective. Countries that balance public provision with regulated private markets tend to achieve broader coverage, though each approach carries trade-offs in cost, quality, and access. The evidence suggests that contextual factors—including political culture, fiscal capacity, and demographic pressures—significantly mediate the success of health policy interventions across different national settings.
Lessons for Turkish Politics
The evidence from this particular case of pharmaceutical policy reform supports several more general conclusions regarding the political dynamics that have underpinned the economic and social policy making of the AKP government. First, it appears that the "social face" of the AKP is of a mostly instrumental nature. The strict regulation of prices and profits in the pharmaceutical sector that was implemented after September 2009 needs to be viewed as a redistributive, pro-poor reform. Yet the reform was merely the unintended consequence of other political dynamics.
Evidence-Based Policy and Political Realities
The Brookings Center on Health Policy produces rigorous evidence and analysis to inform healthcare policy debates, reflecting a broader ecosystem of expert institutions shaping the discourse. In California, the Health Benefits Review Program demonstrates how health policy experts help lawmakers make evidence-based decisions on insurance benefits legislation. Research on AKP pharmaceutical price reforms suggests that the "social face" of these policies was largely instrumental, driven by electoral interests rather than genuine commitment to reducing access barriers to public health services. The gap between expert recommendation and political implementation remains one of the central tensions in health policy worldwide.
Technology, Access, and the 2026 Horizon
McKinsey's 2026 healthcare outlook identifies waves of challenging trends alongside glimmers of opportunity in specialty pharmacy and ambulatory care. The American Association of Nurse Practitioners highlights how innovative technologies and care models will make healthcare more personalized, accessible, and focused on patients' everyday lives. Health policy trends for 2025 and beyond point to Medicare coverage expansions, Medicaid restructuring to bolster telehealth, and breakthroughs in genomics and AI integration. The 2026 health policy outlook in the United States will be greatly influenced by executive action, federal government resizing, and the passage of major legislation like the One Big Beautiful Bill Act.
Structural Pressures on Global Healthcare
Healthcare systems across the globe face converging pressures from aging populations, rising chronic disease burdens, and fiscal constraints that limit the scope of public provision. The tension between populist demands for universal access and neoliberal impulses toward market-based efficiency creates recurring policy dilemmas for governments at every level of development. Addressing these systemic challenges requires sustained investment, institutional capacity, and political commitment that often outlast individual electoral cycles.
From Policy to People: Case-Based Insights
Harvard's case program in health and healthcare provides real-world context for discussing regulation, insurance, human rights, public health, and ethics through the interactive case method. The Harvard Chan School of Public Health's case library curates public health cases written by faculty and students in collaboration with partner institutions. The NIHR School for Public Health Research produces impact case studies that highlight how research translates into real-world benefits, including policy implications and dissemination outputs. The Cases in Global Health Delivery collection offers open-access case studies examining the programmatic, organizational, and policy-related decisions that global health leaders face across various disease conditions.